Investors / United States / Solasta Ventures
Solasta Ventures
Venture capital · Boston, MA, United States · North America
Solasta Ventures is a venture capital firm and a wholly-owned subsidiary of South Korean venture capital firm Aju IB Investment. It invests in therapeutics and discovery platforms addressing diseases with unmet medical needs, leveraging its South Korean network to bridge US-Korea partnerships.
Invests inHealthcare & Biotech
In its own wordslife sciencestherapeuticsbiotechdrug discoveryhealthcareoncology
Your fit with Solasta Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSolasta Ventures lists 26 checked portfolio companies on its own site and is named in 5 funding rounds. Its most frequent entry is Series A, 75% of the companies with a known first round. Its largest themes are Healthcare & Biotech (89%), Industrial & Manufacturing (4%) and Robotics & Hardware (4%). 87% of its companies are based in United States. It invests most often alongside Hatteras Venture Partners, RA Capital and 5AM Ventures.
Counts come from funding rounds that name Solasta Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Solasta Ventures' whole history. Rounds on record name 5 companies; its own site lists 26. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundSolasta Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 75% |
| Series B | 25% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 4 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 60th | 25 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 72th | 8% of companies confirmed by a round |
| Sector focus | 95th | 89% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Hatteras Venture Partners | 5 |
| RA Capital | 4 |
| 5AM Ventures | 3 |
| Atlas Venture | 3 |
| Sanofi Ventures | 3 |
| Sofinnova | 3 |
| Avoro Capital Advisors | 2 |
| Bay City Capital | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2492%
- No longer answers00%
- Points to another company28%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 89% | 15% |
| Industrial & Manufacturing | 4% | 7% |
| Robotics & Hardware | 4% | 1% |
| AI & Machine Learning | 4% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Hatteras Venture Partners
Compare Solasta Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Solasta Ventures| Date | Company | Stage |
|---|---|---|
| 12 Aug 2026 | Series B | |
| 17 Dec 2025 | Series A | |
| 30 Sept 2025 | Series A | |
| 22 Sept 2025 | Round | |
| 17 Mar 2025 | Series A |
Round details for Solasta Ventures
Amounts, full round histories and every co-investor in Solasta Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
26 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Apellis develops life-changing medicines for patients with debilitating diseases | Healthcare & Biotech | Portfolio page | ||
| Arvinas develops targeted protein degradation therapeutics for serious diseases, particularly in neurology and oncology. | Healthcare & Biotech | Portfolio page | ||
| Atea Pharmaceuticals is a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases. | Healthcare & Biotech | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Clearside Biomedical, Inc. is an intellectual property holding, investment, and commercialization company with a portfolio of intellectual property covering its proprietary ocular drug-delivery platform and microinjector technology. | Healthcare & Biotech | Portfolio page | ||
| Ensoma is an in vivo hematopoietic stem cell engineering company that creates a new kind of genomic medicine for patients around the world. | Healthcare & Biotech | Sept 2025Round | Page + round | |
| EvolveImmune Therapeutics develops cancer immunotherapies, including a pipeline of trispecific T cell engagers with integrated CD2 costimulation. | Healthcare & Biotech | Portfolio page | ||
| G1 Therapeutics develops and delivers next generation therapies to improve the lives and outcomes of people living with cancer. | Healthcare & Biotech | Portfolio page | ||
| HotSpot Therapeutics is pioneering a new approach to allosteric drug discovery for the treatment of autoimmune disease | Healthcare & Biotech | Portfolio page | ||
| Immunitas Therapeutics discovers and develops novel therapeutics for patients with cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| InduPro develops proximity-based therapeutics by manipulating protein interactions on the cell surface to treat diseases. | Healthcare & Biotech | Aug 2026Series B | Funding round | |
Healthcare & Biotech | Portfolio page | |||
| Kymera Therapeutics develops medicines that target the fundamental drivers of disease using targeted protein degradation | Healthcare & Biotech | Portfolio page | ||
| Maxion Therapeutics creates protein therapeutics for treating diseases using its KnotBody technology | Healthcare & Biotech | Mar 2025Series A | Page + round | |
| Molecular Templates, Inc. was a clinical-stage biopharmaceutical company | Healthcare & Biotech | Portfolio page | ||
| Orionis Biosciences develops novel precision medicines to fight cancer | Healthcare & Biotech | Portfolio page | ||
| Rallybio develops treatments for rare diseases, particularly those related to complement dysregulation and hematology. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| ReCode Therapeutics develops therapeutics for genetically defined diseases with a focus on cystic fibrosis. | Healthcare & Biotech | Portfolio page | ||
| Seer develops and provides proteomics products and services for research and development in the pharmaceutical and biopharmaceutical industries | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- solasta-ventures.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 17 Mar 2025
- Companies checked
- 26
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Solasta Ventures' profile as data
Pull Solasta Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/solasta-ventures.com
# also
GET /v1/firms/solasta-ventures.com/portfolio
GET /v1/firms/solasta-ventures.com/coinvestors
GET /v1/firms/solasta-ventures.com/news